Record day: U.S. direct-to-consumer sales exceeded $92,000 on October 11, 2026, the highest single day to date$902,000 in 30 days:...
SHELTON, CT / ACCESS Newswire / October 13, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader...
Originally published on CVS Health Company Newsroom HARTFORD, CT / ACCESS Newswire / October 13, 2026 / Aetna®, a CVS...
Originally published on preventcancer.orgThis post has been sponsored by Bristol Myers Squibb as part of its sponsorship of the 2026...
CAMBRIDGE, MA / ACCESS Newswire / October 13, 2026 / Moderna, Inc. (NASDAQ:MRNA), today announced that it will host a...
Leading Health IT Company has Implemented Cost Control Measures and Refocused Remaining Workforce Towards ChemoFx® Commercialization with Hospital Systems, HMOs,...
Critical Manufacturing Milestone Supports Supply Chain Readiness and Planned Phase 2b Clinical Trial Initiation in First Quarter 2027King of Prussia,...
Dusk to Dawn Urgent Care is widening breast‑screening services for uninsured communities LOS ANGELES, CA / ACCESS Newswire / October...
Landmark partnership unites Function's lab testing and its Medical Intelligence (MI) with Google Health personalized guidance and Google wearables to...
Breakthrough Nine-Amino-Acid Peptide Designed to Restore the Immune System's Ability to Eliminate Senescent Cells, With Clinical Entry Planned for 2026MIAMI,...
Humana adds ChemoFx® to its Medicaid Pharmacogenomics Testing coverage policy TAMPA, FL / ACCESS Newswire / October 12, 2026 /...
Second FDA Fast Track Designation for Opamtistomig Underscores Its Potential in Immunologically Cold TumorsNANJING, China, Oct. 12, 2026 (GLOBE NEWSWIRE)...
BEIJING, Oct. 11, 2026 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the...
– Significant performance improvement seen across all subtypes of advanced precancerous lesions, which are important to detect for potential colorectal...
SINGAPORE, Oct. 09, 2026 (GLOBE NEWSWIRE) -- CytoMed Therapeutics Limited (the “Company”) (NASDAQ: GDTC), a Singapore-based clinical stage biopharmaceutical company...
PRESS RELEASE AB SCIENCE REPORTS ITS FINANCIAL RESULTS FOR THE FIRST HALF OF 2026 AND KEY EVENTS OF THE PERIOD...
Communication with FDA at recent Type B meeting provided clear guidance for next steps to prepare IND application to support...
Fort Lee, NJ, Oct. 09, 2026 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (NASDAQ: NVCT) ("Nuvectis" or the "Company"), a clinical-stage...
Collaboration will educate physicians and prostate cancer centers on the complementary roles of Telix’s PSMA-PET molecular imaging technologies and Profound’s...
Acquisition of the AI imaging orchestration pioneer expands Sopris Capital's healthcare technology platform and reinforces its commitment to end-to-end, AI-enabled...